CA46819-2 - 0x000000000000673F
Males & Females of Non-Childbearing Potential
Lotus
* Stipend may pay up to reflected amount.
Start Date:
August 22, 2025 - 8:15am
End Date:
October 2, 2025 - 11:30am
Study Details
Study Number: CA46819
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to £
5,650
Study Criteria
Age: 18 - 55
BMI: 18 - 29.9
Weight Restriction: minimum weight 50 lbs
Study Information
Indication: This investigational medication is being developed to treat chronic inflammatory diseases such as chronic hives and dermatitis.
Route of Administration: Oral
Blood Draws: 28
Study Schedule
Schedule Type: Long Term
Study Length: 12 Night Stay & 1 Phone Call
Screening Dates:
| Event Day | Event Date | Site |
|---|---|---|
| Tuesday | Jul 29 2025 | Belfast |
| Wednesday | Jul 30 2025 | Belfast |
| Thursday | Jul 31 2025 | Belfast |
Doctor Exam Dates:
| Event Day | Event Date | Site |
|---|---|---|
| Tuesday | Jul 29 2025 | Belfast |
| Wednesday | Jul 30 2025 | Belfast |
| Thursday | Jul 31 2025 | Belfast |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Friday | Aug 22 2025 8:15AM | Wednesday | Sep 3 2025 9:00AM | 1 | Belfast |
| Phone participant | Thursday | Oct 2 2025 11:30AM | 1 | Belfast |
